Philips losses worse than expected in 2024

Philips losses worse than expected in 2024

Philips losses were deeper than expected in 2024
Philips losses were deeper than expected in 2024. Photo: LEX VAN LIESHOUT / ANP/AFP
Source: AFP

Philips on Wednesday posted worse-than-expected losses in 2024, as the Dutch medical device maker bids to turn the page on a damaging recall of faulty sleep machines.

The firm reported a net loss of 698 million euros for the full year 2024, compared to the 463-million-euro loss it posted in 2023.

Chief executive Roy Jakobs noted "double-digit declines in demand in both consumer and health systems in China" as well as "a persistently challenging macro environment" as reasons for the losses.

Analysts polled by the company were expecting a full-year loss of 65 million euros and sales of 18.0 billion euros.

Total sales for 2024 came in as forecast at 18.0 billion euros, compared to the 18.1 billion euros gained in 2023.

In November, the firm had lowered its full-year sales target, blaming a drop in demand from Chinese hospitals. That caused stocks to plunge by more than 11 percent.

Read also

Japan 2024 growth slows despite stronger fourth quarter

Once famous for making lightbulbs and televisions among other products, Amsterdam-based Philips in recent years has sold off subsidiaries to focus on medical care technology.

Since 2021, the company has been battling a series of crises over its DreamStation machines for sleep apnoea, a disorder in which breathing stops and starts during sleep.

Millions of devices were recalled over concerns that users were at risk of inhaling pieces of noise-cancelling foams and fears it could potentially cause cancer.

In April, it announced it had reached a $1.1 billion deal to settle US lawsuits from the faulty machines.

Philips got a boost the day before the results when the French agency for medical safety said it could sell its respirators in the country again.

"We strengthened our fundamentals and resolved significant US litigation relating to the Respironics recall," said Jakobs.

Looking ahead, the firm said it expected sales growth of between one and three percent.

Read also

Most Asian markets start week on positive note

These results would be hit by a "mid-to high-single-digit decline in China," the company warned.

"We remain confident in our long-term plan," said Jakobs.

For the fourth quarter, Philips posted a net loss of 333 million euros on sales of 5.0 billion euros.

Analysts had forecast fourth-quarter profits of 302 million euros and sales of 5.1 billion euros.

The firm has continued to shed jobs. It employed 67,823 people at the end of 2024, compared to 69,656 at the end of 2023.

PAY ATTENTION: Сheck out news that is picked exactly for YOU ➡️ find the “Recommended for you” block on the home page and enjoy!

Source: AFP

Authors:
AFP avatar

AFP AFP text, photo, graphic, audio or video material shall not be published, broadcast, rewritten for broadcast or publication or redistributed directly or indirectly in any medium. AFP news material may not be stored in whole or in part in a computer or otherwise except for personal and non-commercial use. AFP will not be held liable for any delays, inaccuracies, errors or omissions in any AFP news material or in transmission or delivery of all or any part thereof or for any damages whatsoever. As a newswire service, AFP does not obtain releases from subjects, individuals, groups or entities contained in its photographs, videos, graphics or quoted in its texts. Further, no clearance is obtained from the owners of any trademarks or copyrighted materials whose marks and materials are included in AFP material. Therefore you will be solely responsible for obtaining any and all necessary releases from whatever individuals and/or entities necessary for any uses of AFP material.